We invest in young companies with innovative technology and high growth potential in the field of specialty chemicals.
The growth engines of Evonik provide four broad areas of focus:
Health & Care
Companies with solutions to problems that address these four growth engines and/or enhance the digital transformation, are of relevance. In addition our deal flow sourcing also supports the six growth fields of Evonik.
a clear growth strategy
a highly motivated, focused management team
a clear, distinctive selling point
a secure IP position
With EUR 250 million under management, we generally maintain a minority share and are able to invest up to EUR 15 million per company
in early-stage companies with an established proof of concept, typically in series A & B rounds
in later-stage companies looking to accelerate growth
typically in syndication with other venture capital investors
Successfully implementing a growth strategy requires more than just money. Evonik as one of the world’s leading providers of specialty chemicals brings additional strategic capabilities to the partnership.
Technological expertise and infrastructure
Market experience and access
A global distribution network
Expertise in patent strategies and on issues of industrial property rights
We invest globally with a focus on Europe, North America and Asia.